PUBLISHER: The Business Research Company | PRODUCT CODE: 1731058
PUBLISHER: The Business Research Company | PRODUCT CODE: 1731058
Valley Fever Global Market Report 2025
Valley fever, also known as coccidioidomycosis, is a fungal infection that mainly affects the lungs, causing symptoms such as cough, fever, fatigue, and chest pain. In some cases, it can lead to severe complications. The infection is caused by inhaling airborne spores from the coccidioides fungi, which are commonly found in dry, dusty soil and become airborne when the soil is disturbed.
The primary treatment options for valley fever include fluconazole, itraconazole, voriconazole, posaconazole, and others. Fluconazole is an antifungal medication that works by inhibiting the growth of fungi to treat fungal infections. The infection can affect various sites, including the skin, lungs, liver, bones, heart, brain, and the membranes surrounding the brain and spinal cord. These treatments are used for a range of end-users, including humans, cattle, sheep, goats, camels, and others.
The valley fever market research report is one of a series of new reports from The Business Research Company that provides valley fever market statistics, including valley fever industry global market size, regional shares, competitors with a valley fever market share, detailed valley fever market segments, market trends and opportunities, and any further data you may need to thrive in the valley fever industry. This valley fever market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The valley fever market size has grown strongly in recent years. It will grow from $0.99 billion in 2024 to $1.05 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historic period can be attributed to factors such as the increasing effects of climate change driving the spread of fungal infections, rising research funding for Valley Fever treatments, greater investments in healthcare, growing demand for specialized diagnostic laboratories, and a rising incidence of Valley Fever in non-endemic regions.
The valley fever market size is expected to see strong growth in the next few years. It will grow to $1.29 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The projected growth during the forecast period can be attributed to factors such as the increasing adoption of telemedicine, a rise in research on antifungal resistance, growing funding for vaccine development, higher population movement across high-risk areas, and the expanding availability of antifungal treatments. Key trends expected in this period include technological innovations, a surge in demand for antifungal drugs, advancements in vaccine development, the continued growth of telemedicine, and enhanced cross-border collaboration.
The increasing exposure to fungus spores is expected to drive the growth of the valley fever market. Fungus spores are tiny reproductive units produced by fungi that can spread through air, water, or surfaces, allowing the fungus to grow and reproduce in new environments. Exposure to these spores has been rising due to factors such as deforestation and shifting weather patterns, which disrupt the soil and promote the release of spores. This leads to a higher risk of infections such as valley fever, particularly in arid regions where the coccidioides fungus thrives. Valley fever treatments help those exposed to fungal spores by alleviating symptoms, preventing complications, and controlling fungal growth, ultimately improving recovery and quality of life. For example, in September 2024, the International Society for Infectious Diseases reported that invasive fungal infections affect about 6.5 million people annually, causing nearly 3.8 million deaths, with approximately 2.5 million deaths directly related to these infections. Therefore, the rising exposure to fungus spores is fueling the growth of the valley fever market.
The growth of healthcare facilities is anticipated to boost the valley fever market. Healthcare facilities refer to the essential infrastructure, systems, and resources required to provide effective healthcare services. The expansion of healthcare infrastructure is driven by advances in medical technology, as innovations such as telemedicine, robotic surgery, and AI-driven diagnostics require upgraded facilities, specialized equipment, and improved healthcare delivery systems to enhance patient outcomes and operational efficiency. These facilities support the treatment of valley fever by offering early diagnosis, antifungal treatments, patient education, and ongoing care to manage symptoms and prevent complications. For instance, the American Hospital Association reported that in 2024, there were 6,120 hospitals in the United States, up from 6,093 in 2022. As a result, the growth in healthcare infrastructure is driving the expansion of the valley fever market.
Companies in the valley fever market are focusing on developing innovative vaccines to combat the growing threat of fungal infections. These vaccines aim to protect individuals by using advanced scientific methods and manufacturing techniques, which enhance public health and safety. For instance, in August 2024, Anivive Lifesciences Inc., a U.S.-based pet pharmaceutical company, received a contract worth up to $33 million from the National Institute of Allergy and Infectious Diseases (NIAID) to develop a human vaccine for valley fever. The funding will support further manufacturing, formulation, extensive safety testing, and a Phase 1 clinical trial, with the goal of delivering the first vaccine to prevent this serious systemic fungal infection.
Major players in the valley fever market are Merck & Co. Inc., Fresenius Kabi, Dr. Reddy's Laboratories, Horster Life Science, Mankind Pharma, Atom Pharma, Ravoos Laboratories, Casca Remedies, Hema Pharmaceuticals, Globela Pharma, Spansules Pharmatech, Sanes Pharmaceuticals, CDH Chemicals, Sainor Laboratories, Maithili Life Sciences, Stratechem (I) Pvt. Ltd., Shantam Pharma, Cerata Pharmaceuticals, Aden Healthcare, Kabir Lifesciences.
North America was the largest region in the valley fever market in 2024. The regions covered in valley fever report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the Valley Fever market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The valley fever market consists of sales of antifungal medications and steroids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Valley Fever Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on valley fever market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for valley fever ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The valley fever market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Types Of Treatment: Fluconazole; Itraconazole; Voriconazole; Posaconazole; Others Types Of Treatment
- 2) By Site Of Infection: Skin; Lungs; Liver; Bones; Heart; Brain; Membranes That Surround The Brain And Spinal Cord; Other Sites Of Infection
- 3) By End-Users: Human; Cattle; Sheep And Goats; Camel; Other End-Users
- Sub Segments:
- 1) By Fluconazole Type: Oral Fluconazole; Intravenous Fluconazole
- 2) By Itraconazole Type: Capsule Itraconazole; Oral Solution Itraconazole
- 3) By Voriconazole Type: Oral Voriconazole; Intravenous Voriconazole
- 4) By Posaconazole Type: Oral Suspension Posaconazole; Delayed-Release Tablets Posaconazole; Intravenous Posaconazole
- 5) By Other Treatment Types: Combination Therapy; Adjunctive Therapy
- Companies Mentioned: Merck & Co. Inc.; Fresenius Kabi; Dr. Reddy's Laboratories; Horster Life Science; Mankind Pharma
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Valley Fever Market Characteristics
3. Valley Fever Market Trends And Strategies
4. Valley Fever Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Valley Fever Growth Analysis And Strategic Analysis Framework
- 5.1. Global Valley Fever PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Valley Fever Market Growth Rate Analysis
- 5.4. Global Valley Fever Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Valley Fever Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Valley Fever Total Addressable Market (TAM)
6. Valley Fever Market Segmentation
- 6.1. Global Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Fluconazole
- Itraconazole
- Voriconazole
- Posaconazole
- Others Types Of Treatment
- 6.2. Global Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Skin
- Lungs
- Liver
- Bones
- Heart
- Brain
- Membranes That Surround The Brain And Spinal Cord
- Other Sites Of Infection
- 6.3. Global Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Human
- Cattle
- Sheep And Goats
- Camel
- Other End-Users
- 6.4. Global Valley Fever Market, Sub-Segmentation Of Fluconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral Fluconazole
- Intravenous Fluconazole
- 6.5. Global Valley Fever Market, Sub-Segmentation Of Itraconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Capsule Itraconazole
- Oral Solution Itraconazole
- 6.6. Global Valley Fever Market, Sub-Segmentation Of Voriconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral Voriconazole
- Intravenous Voriconazole
- 6.7. Global Valley Fever Market, Sub-Segmentation Of Posaconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral Suspension Posaconazole
- Delayed-Release Tablets Posaconazole
- Intravenous Posaconazole
- 6.8. Global Valley Fever Market, Sub-Segmentation Of Others Types Of Treatment, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Combination Therapy
- Adjunctive Therapy
7. Valley Fever Market Regional And Country Analysis
- 7.1. Global Valley Fever Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Valley Fever Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Valley Fever Market
- 8.1. Asia-Pacific Valley Fever Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Valley Fever Market
- 9.1. China Valley Fever Market Overview
- 9.2. China Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Valley Fever Market
- 10.1. India Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Valley Fever Market
- 11.1. Japan Valley Fever Market Overview
- 11.2. Japan Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Valley Fever Market
- 12.1. Australia Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Valley Fever Market
- 13.1. Indonesia Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Valley Fever Market
- 14.1. South Korea Valley Fever Market Overview
- 14.2. South Korea Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Valley Fever Market
- 15.1. Western Europe Valley Fever Market Overview
- 15.2. Western Europe Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Valley Fever Market
- 16.1. UK Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Valley Fever Market
- 17.1. Germany Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Valley Fever Market
- 18.1. France Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Valley Fever Market
- 19.1. Italy Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Valley Fever Market
- 20.1. Spain Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Valley Fever Market
- 21.1. Eastern Europe Valley Fever Market Overview
- 21.2. Eastern Europe Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Valley Fever Market
- 22.1. Russia Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Valley Fever Market
- 23.1. North America Valley Fever Market Overview
- 23.2. North America Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Valley Fever Market
- 24.1. USA Valley Fever Market Overview
- 24.2. USA Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Valley Fever Market
- 25.1. Canada Valley Fever Market Overview
- 25.2. Canada Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Valley Fever Market
- 26.1. South America Valley Fever Market Overview
- 26.2. South America Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Valley Fever Market
- 27.1. Brazil Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Valley Fever Market
- 28.1. Middle East Valley Fever Market Overview
- 28.2. Middle East Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Valley Fever Market
- 29.1. Africa Valley Fever Market Overview
- 29.2. Africa Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Valley Fever Market Competitive Landscape And Company Profiles
- 30.1. Valley Fever Market Competitive Landscape
- 30.2. Valley Fever Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Dr. Reddy's Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Horster Life Science Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Mankind Pharma Overview, Products and Services, Strategy and Financial Analysis
31. Valley Fever Market Other Major And Innovative Companies
- 31.1. Atom Pharma
- 31.2. Ravoos Laboratories
- 31.3. Casca Remedies
- 31.4. Hema Pharmaceuticals
- 31.5. Globela Pharma
- 31.6. Spansules Pharmatech
- 31.7. Sanes Pharmaceuticals
- 31.8. CDH Chemicals
- 31.9. Sainor Laboratories
- 31.10. Maithili Life Sciences
- 31.11. Stratechem (I) Pvt. Ltd.
- 31.12. Shantam Pharma
- 31.13. Cerata Pharmaceuticals
- 31.14. Aden Healthcare
- 31.15. Kabir Lifesciences
32. Global Valley Fever Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Valley Fever Market
34. Recent Developments In The Valley Fever Market
35. Valley Fever Market High Potential Countries, Segments and Strategies
- 35.1 Valley Fever Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Valley Fever Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Valley Fever Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
